(Q42500178)

1 November 2017

title

E-cadherin expression is frequently reduced in infiltrative basal cell carcinoma (English)

1 reference

1 November 2017

Pizarro A

1

1 reference

1 November 2017

publication date

1 December 2000

1 reference

The Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

27

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

804-805

1 reference

E-cadherin expression in skin tumors using an AMeX immunohistostaining method.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

Expression of E-cadherin in skin carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

E-cadherin expression in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

E-cadherin expression in basal cell carcinoma: association with local invasiveness but not with metastatic inefficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2000.TB02287.X

10.1111/J.1346-8138.2000.TB02287.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference